KMTS

Kestra Medical Technologies Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth 3/10
  • Momentum 0/10
Kestra Medical Technologies sales and earnings growth
KMTS Growth
Neutral
  • Revenue Y/Y 62.06%
  • EPS Y/Y 15.92%
  • FCF Y/Y -31.42%
Kestra Medical Technologies gross and profit margin trends
KMTS Profitability
Neutral
  • Gross margin 46.40%
  • EPS margin -186.90%
  • ROIC -180.50%
Kestra Medical Technologies net debt vs free cash flow
KMTS Risk
Great
  • Debt / Equity 0.3
  • Debt / FCF 0.0
  • Interest coverage -16.8

Kestra Medical Technologies stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗